Catyalyst Pharma (CPRX) Surges on Dramatic Analyst Upgrade
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Catyalyst Pharma (NASDAQ: CPRX) is surging in early trade following this morning's 'hot' upgrade from Piper Jaffray, which set a $4 price target on the $1 stock. Shares last traded up 26.8% on volume that is running 71x normal.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SunEdison (SUNEQ) Shares Ramp to Session Highs
- SemiLEDS (LEDS) Active, Shares Gain
- Under Armour (UA) puts active onto Q3 and outlook
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesPiper Jaffray
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!